The role of distinct co-mutation patterns with TP53 mutation in immunotherapy for NSCLC
Sign Up to like & getrecommendations! Published in 2020 at "Genes and Diseases"
DOI: 10.1016/j.gendis.2020.04.001
Abstract: Abstract TP53 mutations was reported to be correlated to the efficacy of program death-1 (PD-1) and program death ligand-1 (PD-L1). The role of co-mutations of TP53 with other recurrently mutated genes in outcome of anti-PD-(L)1… read more here.
Keywords: mutation 240; tp53 mutation; nsclc patients; longer pfs ... See more keywords